Clinical Trials Directory

Trials / Completed

CompletedNCT03045445

"Double Low-Dose" DECT for HCC Imaging

Comparison of Image Quality Between "Double Low-Dose" Dual Energy Liver CT and Standard Contrast Enhanced Liver CT in Patients at High-risk of HCC: Prospective, Randomized Single Center Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: double low-dose protocol provide better lesion conspicuity than standard protocol CT in patients at high-risk of HCC. patients who are scheduled for CECT for HCC diagnosis or surveillance are eligible for this study and allocated to either standard protocol or double-low dose protocol using spectral CT with low radiation dose and low dose of contrast media, within clinically accpetable range.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDouble Low-Dose protocol CTDouble low-dose protocol CT (Low radiation dose quadriphasic liver CT and low dose of iodine contrast media) at spectral dual energy CT scanner
DIAGNOSTIC_TESTStandard protocol CTstandard protocol CT (standard dose quadriphasic liver CT and standard dose of iodine contrast media) at spectral dual energy CT scanner

Timeline

Start date
2017-05-30
Primary completion
2018-03-21
Completion
2019-09-25
First posted
2017-02-07
Last updated
2021-03-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03045445. Inclusion in this directory is not an endorsement.